<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Awaiting price reaction for this filing.
Span Divergent Ltd (formerly Span Diagnostics Ltd), listed on BSE with scrip code 524727, has filed the SEBI-mandated Annexure B2 annual disclosure for FY 2024-25. The company confirmed that it is NOT classified as a Large Corporate as per the SEBI circular dated November 26, 2018. All relevant fields — incremental borrowing, mandatory borrowing through debt securities, actual borrowing through debt securities, shortfall carried forward, and penalty — are reported as Nil / Not Applicable. The 2-year block period covered is FY 2024-25 and FY 2025-26. The disclosure is signed by the Whole-time Director & CFO (Paras Desai) and the Company Secretary & Compliance Officer (Urvi Shinde).
This is a routine regulatory compliance filing with no financial impact on shareholders. It confirms that the company does not meet the Large Corporate criteria and therefore has no mandatory debt issuance obligations or penalties under this framework. No material effect on stock price is expected.